Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of central nervous system (CNS) agents and receptor modulators. Its structure supports the creation of bioactive molecules with improved metabolic stability and binding affinity. Commonly employed in medicinal chemistry for constructing piperidine-based drug candidates, especially in programs targeting neurological disorders and psychiatric conditions. The difluoro substitution enhances lipophilicity and membrane permeability, making it valuable in optimizing pharmacokinetic properties of new drug entities.